Back to Treatments

Treatment

Acalabrutinib

1
Conditions
83
Trials
7,000
Participants
45%
Average Safety

Condition Evidence

Chronic lymphoid leukemia

83 trials · 7,000 participants

88% effectiveness · 45% safety
Acalabrutinib | DFDA